pharma · Unstable Angina Pectoris · Gastric Carcinoma · COLL
COLLEGIUM PHARMACEUTICAL
COLLEGIUM PHARMACEUTICAL, INC
COLLEGIUM PHARMACEUTICAL clinical programs — 17 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 100 Technology Center Dr, Stoughton, Massachusetts 02072, US
- Employees
- 617
- Programs
- 29
- Drugs
- 48
- Patents
- 28
COLLEGIUM PHARMACEUTICAL projects
17 ClinicalTrials.gov programs sponsored by COLLEGIUM PHARMACEUTICAL.
COLLEGIUM PHARMACEUTICAL has 17 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AERD-COV19
COLLEGIUM PHARMACEUTICAL, INC
aspirin-exacerbated respiratory disease
1 trial -
CADET-PAD
COLLEGIUM PHARMACEUTICAL, INC
Ischemia of the lower limbs in the course of obstructive artery disease
1 trial -
DICES
COLLEGIUM PHARMACEUTICAL, INC
Breast cancer
1 trial -
De-escalation to ticagrelor 60 mg at day 30
COLLEGIUM PHARMACEUTICAL, INC
Non ST Segment Elevation Acute Coronary Syndrome
1 trial -
Empagliflozin 10 MG
COLLEGIUM PHARMACEUTICAL, INC
Acute Decompensated Heart Failure
1 trial -
Empagliflozin 20 mg
COLLEGIUM PHARMACEUTICAL, INC
Metabolic Syndrome
1 trial -
Evolocumab
COLLEGIUM PHARMACEUTICAL, INC
Sars-CoV-2 Infection
1 trial -
HLD200 methylphenidate hydrochloride capsules
COLLEGIUM PHARMACEUTICAL, INC
Attention Deficit Hyperactivity Disorder
1 trial -
HYP-NOR
COLLEGIUM PHARMACEUTICAL, INC
hypotension in non-cardiac surgery
1 trial -
IRINOTECAN
COLLEGIUM PHARMACEUTICAL, INC
Gastric Carcinoma
1 trial -
Methoxyflurane - Penthrox
COLLEGIUM PHARMACEUTICAL, INC
ST Elevation Myocardial Infarction
1 trial -
Oxycodone DETERx
COLLEGIUM PHARMACEUTICAL, INC
Chronic Low Back Pain
1 trial -
PB_A&A-ASC-FISTULA_1
COLLEGIUM PHARMACEUTICAL, INC
Anal or recto-cutaneous or recto-vaginal Crohn-related fistula
1 trial -
PREVENT-MINS
COLLEGIUM PHARMACEUTICAL, INC
Myocardial Injury after Noncardiac Surgery
1 trial -
Qarziba 4.5 mg/mL concentrate for solution for infusion
COLLEGIUM PHARMACEUTICAL, INC
Recurrent or progression of neuroblastoma or neuroblastoma or neuroblastoma refractory to first-line treatment.
1 trial -
Ticagrelor 90 mg
COLLEGIUM PHARMACEUTICAL, INC
Myocardial Infarction
1 trial -
Ticagrelor 90mg
COLLEGIUM PHARMACEUTICAL, INC
STEMI
1 trial
Frequently asked questions
How many clinical projects does COLLEGIUM PHARMACEUTICAL have?
17 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.